Hydrogel-based protein array for quantifying epidermal growth factor receptor activity in cell lysates.

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Epidermal growth factor receptor (EGFR) signaling is crucial in many solid tumors, with targeted therapies showing promise.
• Clinical success of anti-EGFR drugs is limited by incomplete assessment of EGFR status and variable patient response.
• Personalized diagnostics are needed to predict patient response to specific anti-EGFR therapies.

Purpose of the Study:

• To develop a hydrogel-based protein array for quantifying EGFR activity directly from cellular extracts.
• To establish a reproducible method for assessing EGFR status in cancer.
• To evaluate the potential for personalized anti-EGFR therapy selection and treatment monitoring.

Main Methods:

• Development of a polyacrylamide hydrogel array functionalized with glutathione S-transferase-fused Eps15 (GST-Eps15) fusion proteins.
• Quantification of EGFR kinase activity using the GST-Eps15 protein array with cell lysates.
• Incubation of the array with tyrosine kinase inhibitors to assess EGFR activity inhibition.

Main Results:

• The hydrogel array successfully quantified EGFR kinase activity in cellular extracts.
• Significant EGFR up-regulation was detected even in diluted samples.
• The array detected inhibition of EGFR activity by various tyrosine kinase inhibitors.

Conclusions:

• The developed protein-acrylamide copolymer hydrogel array is a promising tool for evaluating EGFR status in cancer.
• This array has the potential to guide the selection of optimal anti-EGFR therapeutics for individual patients.
• The array can also be utilized for monitoring treatment progression in cancer patients.